Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: CGM for Insulin-Treated T2DM During Post-Discharge Transition [NA]

View source ↗

Summary

A clinical trial update describing a study evaluating continuous glucose monitoring for insulin-treated type 2 diabetes patients during the post-discharge trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • continuous glucose monitor (CGM)

Snippet

Sponsor: Shanghai 6th People's Hospital | Conditions: Type 2 Diabetes Mellitus (T2DM) | NA | Status: NOT_YET_RECRUITING